TipRanks
Advertisement
Advertisement

HK:9877 Stock Latest News

Jenscare Wins NMPA Approval for JensClip, Accelerates Global Valve Portfolio Push
Company AnnouncementsJenscare Wins NMPA Approval for JensClip, Accelerates Global Valve Portfolio Push
27d ago
9877
Jenscare Wins Hong Kong Approval for LuX-Valve Plus Valve System
PremiumCompany Announcements
Jenscare Wins Hong Kong Approval for LuX-Valve Plus Valve System
1M ago
9877
Jenscare Raises Caps on Connected Medical Device Accessories Deal
PremiumCompany Announcements
Jenscare Raises Caps on Connected Medical Device Accessories Deal
2M ago
9877
Jenscare Scientific Delivers Strong Interim Growth as Structural Heart Portfolio Globalizes
PremiumCompany Announcements
Jenscare Scientific Delivers Strong Interim Growth as Structural Heart Portfolio Globalizes
2M ago
9877
Jenscare Scientific Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
PremiumCompany Announcements
Jenscare Scientific Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
2M ago
9877
Jenscare forecasts sharp interim revenue surge on heart device growth
PremiumCompany AnnouncementsJenscare forecasts sharp interim revenue surge on heart device growth
2M ago
9877
Jenscare Marks Key Milestone in Global Trial for LuX-Valve Plus
Premium
Company Announcements
Jenscare Marks Key Milestone in Global Trial for LuX-Valve Plus
3M ago
9877
Jenscare Wins EU MDR CE Mark for LuX-Valve Plus, Advancing Global Heart-Device Push
Premium
Company Announcements
Jenscare Wins EU MDR CE Mark for LuX-Valve Plus, Advancing Global Heart-Device Push
3M ago
9877
Jenscare Wins Hong Kong Approval for Ken-Valve Heart Valve System
PremiumCompany Announcements
Jenscare Wins Hong Kong Approval for Ken-Valve Heart Valve System
4M ago
9877
Jenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
PremiumCompany Announcements
Jenscare Scientific Reports Poll Results and High Turnout at 2025 AGM
5M ago
9877
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
PremiumCompany Announcements
Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients
5M ago
9877
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
PremiumCompany Announcements
Jenscare Scientific Calls 2025 AGM and Seeks Mandate for New Financing
6M ago
9877
Jenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
PremiumCompany AnnouncementsJenscare’s iJensRobo Heart Valve Robot Completes First Clinical Study in Hong Kong
7M ago
9877
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
Premium
Company Announcements
Jenscare Scientific Posts First Commercial Revenue as Global Valve Portfolio Advances
7M ago
9877
Jenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
Premium
Company Announcements
Jenscare Restructures Finance Leadership and Streamlines Company Secretarial Role
7M ago
9877
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Jenscare Scientific Schedules Board Meeting to Approve 2025 Annual Results
7M ago
9877
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
PremiumCompany Announcements
Jenscare Wins New Zealand Approval for Key Transcatheter Heart Valves
8M ago
9877
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
PremiumCompany Announcements
Jenscare Wins FDA Green Light for Pivotal U.S. Trial of LuX-Valve Plus
8M ago
9877
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
PremiumCompany Announcements
Jenscare Projects Up to RMB110 Million in First-Year Commercial Revenue on Strong Ken-Valve Uptake
9M ago
9877
Jenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
PremiumCompany AnnouncementsJenscare Scientific Shareholders Back Sweeping Governance Changes at 2025 Extraordinary Meeting
10M ago
9877
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
Premium
Company Announcements
Jenscare Seeks CE Mark for JensClip Mitral Valve Repair System in Global Push
10M ago
9877
Jenscare Scientific Cancels Book Closure Period for H Shares
Premium
Company Announcements
Jenscare Scientific Cancels Book Closure Period for H Shares
10M ago
9877

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >